Evolutionarily Conserved Amyloid Aggregation in the PACAP Peptide Family Is Controlled by Heparin-Sensitive Lys/Arg Gatekeeper Residues

This study reveals that evolutionarily conserved amyloid aggregation in the PACAP peptide family is strictly controlled by heparin-sensitive lysine/arginine gatekeeper residues, which act as conditional switches to enable functional fibril formation in secretory granules despite substantial sequence divergence from the glucagon family.

The Gist

Imagine your body's cells as tiny factories that need to store important messages (hormones) in special delivery trucks called "secretory granules." These messages are written in a language of tiny chains called peptides. The problem is, if these chains get too crowded or stick together the wrong way, they can turn into a hard, sticky gunk known as "amyloid," which usually clogs things up and causes trouble.

However, this paper reveals that for a specific family of messages called the PACAP family, this "clogging" isn't a mistake—it's actually a clever storage strategy. Here is how the researchers figured it out, using some simple comparisons:

1. The "Glue" That Only Works Under Pressure

Think of the PACAP peptides as a group of people who naturally want to hold hands and form a long line (an amyloid fibril). But they are very shy; they won't hold hands just anywhere.

• The Setting: They only form these lines inside the specific "warehouse" (secretory granules) where the pH level is just right.
• The Trigger: Even in the right warehouse, they won't link up unless a specific type of "glue" is present. The researchers found that this glue is a molecule called heparin (a type of sugar chain). Without this heparin glue, the peptides stay as individuals. With it, they snap together instantly.

2. The "Gatekeepers" with Red and Blue Buttons

Inside the PACAP peptides, there are special spots rich in Arginine and Lysine (let's call them R/L spots).

• The Switch: Think of these spots as gatekeepers wearing red and blue buttons. Normally, these buttons repel each other (like two magnets with the same pole), keeping the peptide chain open and loose so it can do its job.
• The Change: When the heparin glue (which is negatively charged) comes along, it acts like a magnet that neutralizes those repelling buttons. Suddenly, the gatekeepers stop fighting each other and let the chain fold up and stick to its neighbors. It's a conditional switch: No glue = open; Glue = lock and load.

3. Ancient Cousins and Different Faces

The paper also looked at the family tree. The PACAP family and the Glucagon family (another group of hormones) are like distant cousins who split up billions of years ago.

• The Surprise: Even though their "faces" (the parts that talk to receptors) look very different now, the part of their body that does the "sticking together" (aggregation) has remained almost identical through evolution.
• The Crystal Proof: The researchers built seven crystal models (like 3D puzzles) to prove that even though these cousins have changed their appearance over time, their internal "sticky" mechanism is still the same.

4. The Timeless Blueprint

Finally, the team looked at the "great-grandparents" of these peptides (from ancient sea creatures called protochordates). They found that the basic ability to stick together when the right glue is present has been conserved throughout history.

• The Takeaway: Nature kept the "storage mechanism" (the ability to form amyloid lines) exactly the same for millions of years, even while tweaking the "delivery address" (receptor specificity) so the hormones could talk to different targets.

In short: This paper shows that the PACAP family of hormones uses a smart, ancient trick. They stay loose and ready to go until they reach their storage warehouse and meet a specific "glue" (heparin). That glue flips a switch on their gatekeepers, allowing them to safely pack themselves into tight, amyloid bundles for storage, a trick that has worked for these molecules since the dawn of vertebrate life.

Technical Summary

Technical Summary

Problem Statement
Functional amyloid formation is recognized as a critical mechanism for the storage of various peptide hormones within secretory granules. However, the precise structural basis governing this process remains poorly understood. Specifically, there is a lack of clarity regarding how amyloid formation is regulated within the class B1 GPCR-associated peptide hormone family, particularly concerning the interplay between intrinsic sequence properties and environmental cofactors.

Methodology
The study investigates the aggregation propensity of the PACAP (Pituitary Adenylate Cyclase-Activating Polypeptide) family. The research employs a multi-faceted approach combining:

• Experimental Aggregation Assays: Analyzing fibril formation across a pH range characteristic of secretory granules, with and without the presence of glycosaminoglycans (specifically heparin).
• Molecular Dynamics (MD) Simulations: Modeling the behavior of peptide residues to understand the mechanism of charge compensation and self-assembly.
• Structural Biology: Determining seven amyloid-like crystal structures to visualize the receptor-binding segments.
• Evolutionary Analysis: Profiling aggregation in protochordate-derived peptides to approximate the ancestral state of the superfamily, alongside sequence analysis of vertebrate PACAP-glucagon peptides.

Key Contributions and Results

• Heparin-Dependent Aggregation: The study demonstrates that five of the six human PACAP-family peptides form amyloid fibrils within the physiological pH range of secretory granules. Crucially, this aggregation is strictly dependent on the presence of glycosaminoglycans such as heparin; without these cofactors, the peptides do not aggregate under these conditions.
• Gatekeeper Mechanism: The authors identify conserved Arg/Lys-rich regions within the PACAP family as key regulatory elements. These residues function as "gatekeepers" that prevent spontaneous aggregation. MD simulations and experimental data reveal that these residues act as conditional switches: they inhibit aggregation under normal conditions but promote self-assembly when their positive charges are compensated by polyanionic cofactors like heparin.
• Structural Conservation Despite Sequence Divergence: Although the glucagon and PACAP families diverged early in chordate evolution, the study shows that the receptor-binding segments of PACAP peptides retain aggregation-prone regions. This is supported by seven amyloid-like crystal structures, which indicate that these segments function as aggregation nuclei despite substantial sequence divergence from their glucagon family counterparts.
• Evolutionary Conservation of Aggregation Profiles: By analyzing protochordate-derived peptides and comparing them with vertebrate sequences, the authors find that the intrinsic aggregation profile is remarkably conserved throughout evolution. This conservation persists even as receptor specificity diversifies, suggesting that the capacity for functional amyloid formation is a fundamental, ancient trait of this superfamily.

Significance
The paper establishes that functional amyloid formation in the PACAP family is not an intrinsic, unregulated property of the peptide sequence alone but is a tightly controlled process mediated by "Heparin-Sensitive Lys/Arg Gatekeeper Residues." The findings clarify the structural basis for hormone storage, demonstrating that the evolutionary conservation of aggregation-prone regions is maintained alongside the diversification of receptor specificity. This work provides a mechanistic understanding of how peptide hormones utilize conditional amyloid formation for storage, governed by specific electrostatic interactions with glycosaminoglycans.